MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
TAVR Using CoreValve
World experience and an update of the United States pivotal trial.
By Peter S. Fail, MD, FACC, FACP; Edgar Feinberg, MD, FACS; and Gary Chaisson, RTR, RICA
Current Status of MitraClip
A review of the available data on the utility of this device for treating functional mitral regurgitation.
By Peter S. Fail, MD, FACC, FACP, FSCAI, and Vinod Nair, MD, FACC, FSCAI
Aortic Valve Update
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
THV Expansion
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Abrupt Vessel Closure
A detailed look at the intraprocedural decision making required to handle this challenging presentation.
By Srihari S. Naidu, MD; David Choi, DO; and Peter Angelopoulos, MD
Management of Balloon Undilatable CTOs
An appraisal of the available and potential device and technique options and treatment algorithms used to manage balloon undilatable lesions.
By Peter Tajti, MD; Iosif Xenogiannis, MD; Hatem Najar, MD; and Emmanouil S. Brilakis, MD, PhD
Neuromodulation in Heart Failure: Proven and Emerging Solutions
A summary of the pathophysiologic rationale and latest clinical evidence for the role of interventional neuromodulating therapies in treating heart failure.
By Felix Götzinger, MD; Lucas Lauder, MD; and Felix Mahfoud, MD, MA
Is There a Sex-Related Difference in Response to Renal Denervation?
What do we know, and what questions do we have?
By Zainab Dakhil, FIBMS Cardiol, FABHS Med, FIBMS Med, DM Med, DM Resp, and Sara Al Raisi, MB, BCh, BAO, MRCP(UK), FRACP, PhD
Transcatheter Valve Therapies
By Ted E. Feldman, MD, FSCAI - Chief Medical Editor
Separating Regulatory and Clinical Standards
Understanding the FDA device approval process and the difference between data from premarket and postapproval trials to make informed clinical decisions.
By Gary M. Ansel, MD, and Raghu Kolluri, MD, RVT, RPVI